John Kraus, MD, PhD

home / authors / john-kraus-md-phd

Articles

rural mental health

Harnessing Digital Innovation: Addressing Mental Health Disparities in Rural America

John Kraus, MD, PhD;Jeff Winton

September 19th 2024

How can we improve rural mental health?

digital therapeutic

Rejoyn: A Fundamental Change in How Clinicians Can Treat MDD Symptoms

Leah Kuntz;John Kraus, MD, PhD

April 11th 2024

Rejoyn was recently cleared by the FDA, making it the first prescription digital therapeutic for major depressive disorder.

New research explores ulotaront as an adjunctive therapy for adults with major depressive disorder.

TAAR1 and the Future of MDD Treatment

John Kraus, MD, PhD

December 19th 2022

New research explores ulotaront as an adjunctive therapy for adults with major depressive disorder.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: May 20th 2025

Mini Quiz: Treatment for Pedophilia?

Poor DSM-5—So Misunderstood!

Published: March 23rd 2021 | Updated: May 20th 2025

Poor DSM-5—So Misunderstood!

New Africa /Adobestock

Published: May 18th 2025 | Updated: May 20th 2025

Poster at APA Annual Meeting Explores the Use of GLP-1 Agonists for Antipsychotic-Associated Metabolic Issues

Mini Quiz: Methods of Suicide

Published: January 21st 2016 | Updated: May 20th 2025

Mini Quiz: Methods of Suicide

Mini Quiz: Chronic Methamphetamine Use

Published: January 11th 2020 | Updated: May 20th 2025

Mini Quiz: Chronic Methamphetamine Use

PsychQuiz: Tardive Dyskinesia Risk Factors

Published: April 16th 2021 | Updated: May 20th 2025

PsychQuiz: Tardive Dyskinesia Risk Factors

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.